Depletion of pancreatic lipid improves beta-cell function in early type 2 diabetes
胰腺脂质的消耗可改善早期 2 型糖尿病的 β 细胞功能
基本信息
- 批准号:10379925
- 负责人:
- 金额:$ 53.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipose tissueAdultAfrican AmericanAfrican American populationAmericanBeta CellBlood GlucoseBody CompositionCaloriesCell physiologyCessation of lifeCharacteristicsChildClosure by clampDevelopmentDiagnosisDietDiseaseDisease ProgressionDisease remissionEtiologyEuropeanEventFailureFat-Restricted DietFatty acid glycerol estersFoodGlucose ClampGuidelinesHealth Care CostsHigh PrevalenceHyperglycemiaIndividualInsulinInsulin ResistanceInterventionLife StyleLipidsLongevityMagnetic Resonance ImagingMetabolicMuscleNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusObesityOralPancreasParticipantPatientsPharmacotherapyPhasePopulations at RiskPrediabetes syndromePrevalenceQuality of lifeRaceRandomized Clinical TrialsRecoveryResearchRiskSymptomsTestingThigh structureUnited States Department of AgricultureVisceralWeightbariatric surgeryblood glucose regulationcell injuryclinical caredesigndietary controldisabilityeffective therapyethnic differenceexperienceglycemic controlhealth disparityimprovedinsulin secretioninsulin sensitivitylean body massnon-diabeticpatient populationpreservationpreventracial and ethnicresponserestorationsubcutaneoussugartooltreatment responseweight maintenance
项目摘要
The decline in first-phase insulin secretion is a key event in the etiology of type 2 diabetes (T2D). Although the cause of beta-cell failure is not clear, “lipotoxicity” has been proposed. Bariatric surgery and very-low calorie diets in patients with T2D induce disease remission, characterized by a return of first-phase insulin secretion and a depletion of pancreas lipid. However, these are extreme approaches to treating T2D, and non-invasive, sustainable, yet equally effective, treatments are needed. We have shown in individuals at risk for T2D that an intervention with a weight-maintaining low-glycemic (LG) diet selectively depletes visceral adipose tissue and ectopic lipid in muscle while preserving thigh subcutaneous adipose and lean body mass. This observation suggests that such diets are able to “remodel” body composition by re-partitioning energy away from metabolically harmful lipid stores. Participants on the LG diet also demonstrated improved insulin sensitivity and a dramatic (9-fold) increase in first-phase insulin secretion. Thus, we hypothesize that a weight-maintaining LG diet will selectively deplete ectopic adipose tissue, including pancreatic lipid, and will permit recovery of beta-cell function in individuals with T2D. Rescue of beta-cell function may be particularly important in African-Americans (AA), who as a group demonstrate a high prevalence of T2D, for reasons that cannot be explained by lifestyle. AA are likely to be vulnerable to beta-cell failure due to inherently high beta-cell responsiveness (demonstrable in healthy young children). Further, it has been shown that pancreas lipid is a determinant of prediabetes specifically in AA. Thus, we hypothesize that an LG diet will be particularly beneficial to beta-cell function and glycemic control among AA. To test these hypotheses, we will conduct a randomized clinical trial to examine the impact a weight-maintaining LG diet vs a Control diet (ADA/USDA) with all food provided on changes in pancreatic lipid by magnetic resonance imaging (MRI) and first-phase insulin secretion by hyperglycemic clamp and oral meal test in AA and European-American (EA) individuals with early T2D (<5 yr since diagnosis). The study will be powered to examine race-specific effects (race x diet interaction). This proposal responds to PA-17-021, “Addressing Health Disparities in NIDDK Diseases.” The results from this study could change clinical care guidelines to incorporate an LG diet, which may reduce the disproportionate burden of T2D and its complications experienced by AA.
一期胰岛素分泌下降是2型糖尿病(T2D)病因学中的一个关键事件。虽然β细胞衰竭的原因尚不清楚,但“脂肪毒性”已被提出。T2D患者的减肥手术和极低热量饮食可诱导疾病缓解,其特征是第一阶段胰岛素分泌的恢复和胰腺脂质的消耗。然而,这些都是治疗T2D的极端方法,需要非侵入性、可持续但同样有效的治疗方法。我们已经证明,在有T2D风险的个体中,采用维持体重的低血糖(LG)饮食干预可以选择性地消耗内脏脂肪组织和肌肉中的异位脂质,同时保留大腿皮下脂肪和瘦体重。这一观察结果表明,这种饮食能够通过重新分配能量,从代谢有害的脂质储存中“重塑”身体成分。LG饮食的参与者也表现出胰岛素敏感性的改善,第一阶段胰岛素分泌显著增加(9倍)。因此,我们假设维持体重的LG饮食会选择性地消耗异位脂肪组织,包括胰腺脂质,并允许T2D患者恢复β细胞功能。拯救β细胞功能对于非裔美国人(AA)尤其重要,他们作为一个群体显示出T2D的高患病率,其原因无法用生活方式来解释。由于固有的高β细胞反应性(在健康的幼儿中可以证明),AA可能易受β细胞衰竭的影响。此外,已经表明胰腺脂质是糖尿病前期的决定因素,特别是在AA中。因此,我们假设LG饮食对AA患者的β细胞功能和血糖控制特别有益。为了验证这些假设,我们将进行一项随机临床试验,通过磁共振成像(MRI)、高血糖钳和口服膳食测试对AA和欧美(EA)早期T2D患者(诊断后<5年)胰脂变化的影响,研究维持体重的LG饮食与控制饮食(ADA/USDA)提供所有食物对胰脂变化的影响。这项研究将被用于检查种族特定的影响(种族与饮食的相互作用)。该提案回应了PA-17-021“解决NIDDK疾病的健康差异”。这项研究的结果可能会改变临床护理指南,纳入LG饮食,这可能会减少AA带来的不成比例的T2D负担及其并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W Timothy GARVEY其他文献
W Timothy GARVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W Timothy GARVEY', 18)}}的其他基金
Depletion of pancreatic lipid improves beta-cell function in early type 2 diabetes
胰腺脂质的消耗可改善早期 2 型糖尿病的 β 细胞功能
- 批准号:
9902431 - 财政年份:2018
- 资助金额:
$ 53.28万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 53.28万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 53.28万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 53.28万 - 项目类别: